Cautious comparison between East and West is necessary in terms of the serum pepsinogen test

Digestive Endoscopy

Volumn 21, Issue 2, 2009, Pages 134-135

  Miki, Kazumasa ^a   Fujishiro, Mitsuhiro ^b  

^a The Japan Foundation   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN;

ATROPHIC GASTRITIS; CORRELATION ANALYSIS; HELICOBACTER INFECTION; HUMAN; LETTER; PEPSINOGEN BLOOD LEVEL; PROTEIN BLOOD LEVEL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE PROGRESSION; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; PEPSINOGEN A; STOMACH NEOPLASMS;

EID: 62449295235     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2009.00845.x     Document Type: Letter

References (6)

1. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res. 1992 52 : 6735 40.
2. Miki K, Ichinose M, Shimizu A et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol. Jpn. 1987 22 : 133 41.
3. Miki K, Ichinose M, Kakei N et al. The clinical application of the serum pepsinogen I and II levels as mass screening method for gastric cancer. In : Takahashi K (ed.). Aspartic Proteinases: Structure, Function, Biology and Biomedical Implications. New York : Plenum Press, 1995 139 43.
4. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J. Med. Screen. 2004 11 : 141 7.
5. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006 9 : 245 3.
6. Biohit Corporation. GastroPanel Cited 22 January 2009.] Available from URL: http://www.biohit.com/gastropanel.